SCI时时刷

search
High WEE1 expression is independently linked to poor survival in multiple myeloma
High WEE1 expression is independently linked to poor survival in multiple myeloma
Current prognostic scores in multiple myeloma (MM) currently rely on disease burden and a limited set of genomic alteratio...
Peritoneal lymphomatosis with CD5-positive diffuse large B-cell lymphoma
Peritoneal lymphomatosis with CD5-positive diffuse large B-cell lymphoma
Miyazaki K, Asano N, Yamada T, Miyawaki K, Sakai R, Igarashi T, et al. DA-EPOCH-R combined with high-dose methotrexate in ...
Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma
Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma
Risk stratification models based on cytogenetics and disease burden help identify high-risk patients with newly diagnosed ...
The role of cGAS-STING in remodeling the tumor immune microenvironment induced by radiotherapy
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 9149a...
Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations
Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations
To clarify karyotype evolution of myelodysplastic syndrome or acute myeloid leukemia with TP53 mutations (MDS/AML-TP53), w...
Engineered oncolytic virus coated with anti-PD-1 and alendronate for ameliorating intratumoral T cell hypofunction
Engineered oncolytic virus coated with anti-PD-1 and alendronate for ameliorating intratumoral T cell hypofunction
Glioblastoma is a highly aggressive and devastating primary brain tumor that is resistant to conventional therapies. Oncol...
Zanubrutinib in Japanese treatment-naive and relapsed/refractory patients with Waldenström macroglobulinemia and CLL/SLL
Zanubrutinib in Japanese treatment-naive and relapsed/refractory patients with Waldenström macroglobulinemia and CLL/SLL
Zanubrutinib is a selective second-generation Bruton tyrosine kinase inhibitor approved in various B-cell malignancies glo...
Bispecific Antibody Therapy for Lymphoma
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 912e4...
CAR-macrophages targets CD26 to eliminate chronic myeloid leukemia stem cells
CAR-macrophages targets CD26 to eliminate chronic myeloid leukemia stem cells
Chronic myeloid leukemia stem cells (CML-LSCs), which exhibit resistance to tyrosine kinase inhibitors (TKIs), are the lea...
CD3/CD20/CD45 negative leukemia cutis
CD3/CD20/CD45 negative leukemia cutis
A 56-year-old male presented to the clinic with complaints of multiple skin lesions. A complete blood count (CBC) was not ...
Future directions in the evaluation and management of newly diagnosed metastatic cancer
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 9114c...
Molecular features and clinical actionability of gene fusions in colorectal cancer
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 9114c...